62856-212-01 : NDC 2026 Code

62856-212-01 : Lecanemab ( Leqembi )

Additionally :

You can get information about “62856-212-01” NDC code in 62856-212-01 in HTML format

HTML | 62856-212-01 in TXT (Plain Text) format

TXT | 62856-212-01 in PDF (Portable Document Format)

PDF | 62856-212-01 in XML format

XML formats.

NDC Code : 62856-212-01 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "62856-212-01",
    "PackageDescription": "1 VIAL, SINGLE-DOSE in 1 CARTON (62856-212-01)  / 2 mL in 1 VIAL, SINGLE-DOSE",
    "NDC11Code": "62856-0212-01",
    "ProductNDC": "62856-212",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Leqembi",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Lecanemab",
    "DosageFormName": "INJECTION, SOLUTION",
    "RouteName": "INTRAVENOUS",
    "StartMarketingDate": "20230106",
    "EndMarketingDate": null,
    "MarketingCategoryName": "BLA",
    "ApplicationNumber": "BLA761269",
    "LabelerName": "Eisai Inc.",
    "SubstanceName": "LECANEMAB",
    "StrengthNumber": "100",
    "StrengthUnit": "mg/mL",
    "Pharm_Classes": "Amyloid Beta-directed Antibody Interactions [MoA], Amyloid Beta-directed Antibody [EPC]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2026-02-02",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20271231",
    "StartMarketingDatePackage": "20230106",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}